FlowVax BreastCA is being designed to treat a wide range of breast cancers.
A universal treatment for immediate delivery of widely effective therapy.
Overview
- Under Development, FDA Approval Required.
- Available On-Demand bio-medicine targeting tumor-associated antigens.
- Will work for many breast cancer patients.
- Delivered through intranodal injection
- Engineered with next-generation sequencing and artificial intelligence.
Status
-
Pre-Clinical Feasibility
-
Gene Sequencing Clinical Study
-
Phase I Clinical Study
What is Breast Cancer?
Breast cancer is an abnormal growth disease that most commonly presents as a lump that feels different from the rest of the breast tissue. More than 80% of cases are discovered when a person detects such a lump with the fingertips. The earliest breast cancers, however, are detected by a mammogram.
A scanning electron microscopic 3D-enhanced NIH image of cancer cells and lamellipodia spike processes on a cellular tissue surface. Credit: National Institutes of Health/Department of Health and Human Services